1994
DOI: 10.1002/gcc.2870090213
|View full text |Cite
|
Sign up to set email alerts
|

Amplification of the anonymous marker D17S67 in malignant astrocytomas

Abstract: Loss of heterozygosity (LOH) for chromosome arms 9p, 10p, 10q, and 17p and amplification of the epidermal growth factor receptor (EGFR) gene have been identified as frequent genetic changes in malignant astrocytomas. We have found amplification of the anonymous marker D17S67 on chromosome arm 17p in 10% (3 of 30 cases) of astrocytomas of the highest malignancy grade. The tumors with D17S67 amplification displayed other genetic changes on chromosome 17, including additional amplifications and deletions. All thr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

4
13
0

Year Published

1994
1994
2004
2004

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 13 publications
(17 citation statements)
references
References 16 publications
4
13
0
Order By: Relevance
“…Only in one highgrade astrocytoma we found a 3.5-fold amplification of GOA (GBM 1683, data not shown), suggesting that amplification of this gene is not a frequent event in astrocytomas. This tumor was known to harbor multiple amplification events on chromosome 17 (9).…”
Section: Expression Of Goa In Astrocytomas Andmentioning
confidence: 98%
See 1 more Smart Citation
“…Only in one highgrade astrocytoma we found a 3.5-fold amplification of GOA (GBM 1683, data not shown), suggesting that amplification of this gene is not a frequent event in astrocytomas. This tumor was known to harbor multiple amplification events on chromosome 17 (9).…”
Section: Expression Of Goa In Astrocytomas Andmentioning
confidence: 98%
“…The GOAspecific test probe was a 1470-bp insert of IMAGE clone 2162284, containing the 3Ј half of GOA. Probes were labeled as described for the Northern blotting procedure and hybridized under conditions given previously (9).…”
Section: Southern Blot Analysismentioning
confidence: 99%
“…Previous genetic studies of malignant astrocytomas have identi ed regions of oncogene activation (most commonly gene ampli cation of EGFR at 7p12) (Bello et al, 1994;Bijlsma et al, 1994;Fischer et al, 1994;Leenstra et al, 1994;Muleris et al, 1994;Schrock et al, 1996;von Deimling et al, 1994) as well as tumor suppressor gene inactivation as de ned by LOH. LOH has been reported in gliomas at 9p (MTS1/CDKN2A and MTS2/CDKN2B), 13q (RB), Neuro-Oncology n JU LY 19 9 9 170 E.C.…”
mentioning
confidence: 99%
“…While 17p and 19q13 have been suggested to be important in osteosarcoma by conventional cytogenetics, these regions may be aå ected in higher percentages of osteosarcoma specimens than previously suggested. 17p ampli cation also has been reported in malignant astrocytoma [ 32] . While no speci c gene targets within the 19q12-13 region have been identi ed, candidate genes include AKT2, a gene encoding a Ser/Thr kinase ; ERCC2, a DNA repair gene ; BCL3 that encodes a transcriptional regulator of NFi b ; and TGFb, a gene involved in mesenchymal diå erentiation [33][34][35][36] .…”
Section: Discussionmentioning
confidence: 80%